Lei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lei Wang has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Shinya Tanaka
Department of Cancer Pathology, Faculty of Medicine Hokkaido University Sapporo Japan
15 shared publications - Masumi Tsuda
Hokkaido University
13 shared publications - Jumpei Ito
Laboratory of Virus Informatics, Department of Biological Informatics, Bioinformatics Center, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan
9 shared publications - Kei Sato
Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo
9 shared publications - Kumiko Yoshimatsu
Laboratory of Animal Experimentation, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan
9 shared publications Rigel Suzuki
Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
9 shared publications
Latest Publications
- 7 October 2026
- Published by Wiley in Pathology International
- Vol. 76 (10) , e70184
Reduced Gene Module for Spatial Transcriptomics Recapitulates Single‐Cell Molecular Classifications of Glioblastoma
Glioblastoma, IDH ‐wildtype, is the most common and malignant adult‐type diffuse glioma. It is characterized by extensive heterogeneity and poor prognosis. Recent single‐cell RNA‐sequencing studies have revealed distinct transcriptional programs that define cellular states such as astrocyte‐like, mesenchymal‐like, neural‐progenitor‐cell‐like, and oligodendrocyte‐progenitor‐cell‐like. However, their spatial context remains unclear because of the limitations of single‐cell and spot‐based spatial transcriptomics. In the present study, we applied a single‐cell molecular classification of glioblastoma to a spatial transcriptomic analysis using the Xenium in situ platform. A custom gene panel comprising 366 genes, including 100 additional genes beyond the predesigned central nervous system panel, was designed to enable high‐resolution, cell‐level analysis. We constructed reduced modules derived from the Neftel et al. classification and validated their reproducibility across public single‐cell datasets, achieving approximately 80% concordance with the original modules. In three cases of glioblastoma, IDH ‐wildtype, spatial transcriptomic profiling revealed regional variations in transcriptional states; cellular tumor regions, regions of pseudopalisading necrosis were significantly enriched in reduced neural‐progenitor‐like‐cells subtype 1, and reduced mesenchymal‐like‐cells subtype 2, respectively. Our data indicate that the novel reduced module provides a framework for investigating single‐cell molecular states within a tissue context in glioblastoma.
- 7 October 2026
- Published by Wiley in Pathology International
- Vol. 76 (10) , e70184
Reduced Gene Module for Spatial Transcriptomics Recapitulates Single‐Cell Molecular Classifications of Glioblastoma
Glioblastoma, IDH ‐wildtype, is the most common and malignant adult‐type diffuse glioma. It is characterized by extensive heterogeneity and poor prognosis. Recent single‐cell RNA‐sequencing studies have revealed distinct transcriptional programs that define cellular states such as astrocyte‐like, mesenchymal‐like, neural‐progenitor‐cell‐like, and oligodendrocyte‐progenitor‐cell‐like. However, their spatial context remains unclear because of the limitations of single‐cell and spot‐based spatial transcriptomics. In the present study, we applied a single‐cell molecular classification of glioblastoma to a spatial transcriptomic analysis using the Xenium in situ platform. A custom gene panel comprising 366 genes, including 100 additional genes beyond the predesigned central nervous system panel, was designed to enable high‐resolution, cell‐level analysis. We constructed reduced modules derived from the Neftel et al. classification and validated their reproducibility across public single‐cell datasets, achieving approximately 80% concordance with the original modules. In three cases of glioblastoma, IDH ‐wildtype, spatial transcriptomic profiling revealed regional variations in transcriptional states; cellular tumor regions, regions of pseudopalisading necrosis were significantly enriched in reduced neural‐progenitor‐like‐cells subtype 1, and reduced mesenchymal‐like‐cells subtype 2, respectively. Our data indicate that the novel reduced module provides a framework for investigating single‐cell molecular states within a tissue context in glioblastoma.
- Open Access
- 29 May 2026
- Published by Springer Nature in Nature
- Vol. 654 (8119) , E18
Author Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
- 29 May 2026
- Published by Springer Nature in Nature
- Vol. 654 (8119) , E18
Open AccessAuthor Correction: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
- Open Access
- 18 March 2026
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 52 (2) , e70068
Myofibre Density Reveals a Critical Threshold Around Age 6 in Steroid‐Naïve Duchenne Muscular Dystrophy: A Retrospective Observational Study
Aims: In Duchenne muscular dystrophy (DMD), robust histological markers for assessing early disease progression remain elusive. We defined myofibre density ( MFD ) as the count of myofibres per square millimetre, which, in our preliminary survey of DMD muscle biopsies, steeply declined with age (Spearman's ρ : −0.85). We aimed to characterise age‐dependent MFD dynamics in early‐stage DMD. Methods: We retrospectively assessed 46 archival muscle‐biopsy slides (steroid‐naïve; collected > 40 years ago) using semi‐quantitative image analysis with digital restoration. MFD and classical histological variables were quantified. Age– MFD dynamics were modelled with segmented regression and validated using weakly informative Bayesian modelling. The primary measure was the MFD age‐breakpoint. Secondary measures included breakpoint‐detection power, age‐predictive MFD cut‐offs and behaviour of conventional variables across breakpoint‐defined age bands. Results: After quality and age‐distribution screening, 35 slides (age 1–11 years) were analysed. Segmented regression identified a breakpoint at 6.25 years (95% confidence interval [CI]: 5.08–7.42); after which MFD plateaued at lower levels. Bayesian posterior estimate was 6.37 years (95% credible interval: 5.24–7.66). A 10,000‐run Monte Carlo simulation ( n = 35) showed approximately 80% power to recapture the breakpoint within ±1.25 years. MFD cut‐offs > 596 and < 426 fibres/mm 2 corresponded to 80% and 20% probabilities of age < 6.25 years. Between the early (< 5 years) and late (≥ 7.5 years) age bands defined by the breakpoint–CI limits, myofibre‐size parameters, myofibre area and fat replacement shifted significantly. Conclusions: MFD , a simple metric, reveals a previously unrecognised phase of rapid myofibre loss lasting up to around age 6 in early‐stage DMD.
- 18 March 2026
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 52 (2) , e70068
Open AccessMyofibre Density Reveals a Critical Threshold Around Age 6 in Steroid‐Naïve Duchenne Muscular Dystrophy: A Retrospective Observational Study
Aims: In Duchenne muscular dystrophy (DMD), robust histological markers for assessing early disease progression remain elusive. We defined myofibre density ( MFD ) as the count of myofibres per square millimetre, which, in our preliminary survey of DMD muscle biopsies, steeply declined with age (Spearman's ρ : −0.85). We aimed to characterise age‐dependent MFD dynamics in early‐stage DMD. Methods: We retrospectively assessed 46 archival muscle‐biopsy slides (steroid‐naïve; collected > 40 years ago) using semi‐quantitative image analysis with digital restoration. MFD and classical histological variables were quantified. Age– MFD dynamics were modelled with segmented regression and validated using weakly informative Bayesian modelling. The primary measure was the MFD age‐breakpoint. Secondary measures included breakpoint‐detection power, age‐predictive MFD cut‐offs and behaviour of conventional variables across breakpoint‐defined age bands. Results: After quality and age‐distribution screening, 35 slides (age 1–11 years) were analysed. Segmented regression identified a breakpoint at 6.25 years (95% confidence interval [CI]: 5.08–7.42); after which MFD plateaued at lower levels. Bayesian posterior estimate was 6.37 years (95% credible interval: 5.24–7.66). A 10,000‐run Monte Carlo simulation ( n = 35) showed approximately 80% power to recapture the breakpoint within ±1.25 years. MFD cut‐offs > 596 and < 426 fibres/mm 2 corresponded to 80% and 20% probabilities of age < 6.25 years. Between the early (< 5 years) and late (≥ 7.5 years) age bands defined by the breakpoint–CI limits, myofibre‐size parameters, myofibre area and fat replacement shifted significantly. Conclusions: MFD , a simple metric, reveals a previously unrecognised phase of rapid myofibre loss lasting up to around age 6 in early‐stage DMD.
- 17 February 2026
- Published by Wiley in Pathology International
- Vol. 76 (2) , e70098
Transfer Learning Strategies for Pathological Foundation Models: A Systematic Evaluation in Brain Tumor Classification
Deploying pathology AI at individual hospitals faces challenges including limited cases and adapting pretrained models to local data. Brain tumor classification, with diverse diagnostic categories but few cases per institution, represents this challenge. Foundation models may offer a solution, but optimal transfer learning strategies remain unclear. We evaluated fine‐tuning (FT) versus linear probing (LP) for brain tumor classification using foundation models (UNI, Prov‐GigaPath) and conventional models including ImageNet‐pretrained Vision Transformer (ViT‐L) and CTransPath. Models were trained on an institutional dataset (254 cases: glioblastoma, astrocytoma, oligodendroglioma, PCNSL, and metastatic tumors) and validated on EBRAINS dataset (698 cases). Conventional models maintained FT ≥ LP on both datasets. However, foundation models showed a reversal: FT only marginally outperformed LP on institutional data, and LP significantly outperformed FT on external data ( p < 0.01), suggesting that fine‐tuning may compromise the generalization capabilities of foundation models. Notably, UNI with LP using only 10 patches per case significantly outperformed fine‐tuned conventional models using 500 patches on external validation ( p < 0.001). These findings suggest that for foundation models, fine‐tuning on limited institutional data may cause overfitting, and preserving pre‐trained representations through linear probing enables more efficient AI implementation with better generalization.
- 17 February 2026
- Published by Wiley in Pathology International
- Vol. 76 (2) , e70098
Transfer Learning Strategies for Pathological Foundation Models: A Systematic Evaluation in Brain Tumor Classification
Deploying pathology AI at individual hospitals faces challenges including limited cases and adapting pretrained models to local data. Brain tumor classification, with diverse diagnostic categories but few cases per institution, represents this challenge. Foundation models may offer a solution, but optimal transfer learning strategies remain unclear. We evaluated fine‐tuning (FT) versus linear probing (LP) for brain tumor classification using foundation models (UNI, Prov‐GigaPath) and conventional models including ImageNet‐pretrained Vision Transformer (ViT‐L) and CTransPath. Models were trained on an institutional dataset (254 cases: glioblastoma, astrocytoma, oligodendroglioma, PCNSL, and metastatic tumors) and validated on EBRAINS dataset (698 cases). Conventional models maintained FT ≥ LP on both datasets. However, foundation models showed a reversal: FT only marginally outperformed LP on institutional data, and LP significantly outperformed FT on external data ( p < 0.01), suggesting that fine‐tuning may compromise the generalization capabilities of foundation models. Notably, UNI with LP using only 10 patches per case significantly outperformed fine‐tuned conventional models using 500 patches on external validation ( p < 0.001). These findings suggest that for foundation models, fine‐tuning on limited institutional data may cause overfitting, and preserving pre‐trained representations through linear probing enables more efficient AI implementation with better generalization.
- Open Access
- 14 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity
The global circulation of SARS-CoV-2 in human populations has driven the emergence of Omicron subvariants, which have become highly diversified through recombination. In late 2024, SARS-CoV-2 Omicron XEC variant emerged from the recombination of two JN.1 progeny, KS.1.1 and KP.3.3, and became predominant worldwide. Here, we investigate virological features of the XEC variant. Epidemic dynamics modeling suggests that spike substitutions in XEC mainly contribute to its increased viral fitness. Additionally, four licensed antivirals are effective against XEC. Although the fusogenicity of XEC spike is comparable to that of the JN.1 spike, the intrinsic pathogenicity of XEC in male hamsters is significantly higher than that of JN.1. Notably, we find that the nucleocapsid R204P mutation of XEC enhances inflammation through NF-κB activation. Recent studies suggest that the evolutionary potential of spike protein is reaching its limit. Indeed, our findings highlight the critical role of non-spike mutations in the future evolution of SARS-CoV-2.
- 14 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessA non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicity
The global circulation of SARS-CoV-2 in human populations has driven the emergence of Omicron subvariants, which have become highly diversified through recombination. In late 2024, SARS-CoV-2 Omicron XEC variant emerged from the recombination of two JN.1 progeny, KS.1.1 and KP.3.3, and became predominant worldwide. Here, we investigate virological features of the XEC variant. Epidemic dynamics modeling suggests that spike substitutions in XEC mainly contribute to its increased viral fitness. Additionally, four licensed antivirals are effective against XEC. Although the fusogenicity of XEC spike is comparable to that of the JN.1 spike, the intrinsic pathogenicity of XEC in male hamsters is significantly higher than that of JN.1. Notably, we find that the nucleocapsid R204P mutation of XEC enhances inflammation through NF-κB activation. Recent studies suggest that the evolutionary potential of spike protein is reaching its limit. Indeed, our findings highlight the critical role of non-spike mutations in the future evolution of SARS-CoV-2.
- Top Cited PapersOpen Access
- 6 August 2025
- Published by Springer Nature in Nature
- Vol. 644 (8075) , 89-95
Data-driven de novo design of super-adhesive hydrogels
Data-driven methodologies have transformed the discovery and prediction of hard materials with well-defined atomic structures by leveraging standardized datasets, enabling accurate property predictions and facilitating efficient exploration of design spaces1,2,3. However, their application to soft materials remains challenging because of complex, multiscale structure–property relationships4,5,6. Here we present a data-driven approach that integrates data mining, experimentation and machine learning to design high-performance adhesive hydrogels from scratch, tailored for demanding underwater environments. By leveraging protein databases, we developed a descriptor strategy to statistically replicate protein sequence patterns in polymer strands by ideal random copolymerization, enabling targeted hydrogel design and dataset construction. Using machine learning, we optimized hydrogel formulations from an initial dataset of 180 bioinspired hydrogels, achieving remarkable improvements in adhesive strength, with a maximum value exceeding 1 MPa. These super-adhesive hydrogels hold immense potential across diverse applications, from biomedical engineering to deep-sea exploration, marking a notable advancement in data-driven innovation for soft materials.
- 6 August 2025
- Published by Springer Nature in Nature
- Vol. 644 (8075) , 89-95
Top Cited PapersOpen AccessData-driven de novo design of super-adhesive hydrogels
Data-driven methodologies have transformed the discovery and prediction of hard materials with well-defined atomic structures by leveraging standardized datasets, enabling accurate property predictions and facilitating efficient exploration of design spaces1,2,3. However, their application to soft materials remains challenging because of complex, multiscale structure–property relationships4,5,6. Here we present a data-driven approach that integrates data mining, experimentation and machine learning to design high-performance adhesive hydrogels from scratch, tailored for demanding underwater environments. By leveraging protein databases, we developed a descriptor strategy to statistically replicate protein sequence patterns in polymer strands by ideal random copolymerization, enabling targeted hydrogel design and dataset construction. Using machine learning, we optimized hydrogel formulations from an initial dataset of 180 bioinspired hydrogels, achieving remarkable improvements in adhesive strength, with a maximum value exceeding 1 MPa. These super-adhesive hydrogels hold immense potential across diverse applications, from biomedical engineering to deep-sea exploration, marking a notable advancement in data-driven innovation for soft materials.
- Open Access
Induction of meningioma stem signature via hydrogel reprogramming and application of meningioma stem cell marker CXCR4 to pathological diagnosis and treatment
Backgrounds: Meningioma accounts for about 40% of brain tumors, but there was no effective treatment for recurrent or inoperable cases. We have previously found that when cancer cells are cultured on certain hydrogels, cancer stem cells are efficiently induced in various cancer types and we named this process as hydrogel activated reprogramming (HARP) phenomenon. In this study, we aimed to identify a key molecule that induced meningioma stem cells via hydrogels. Methods: Meningioma cells cultured on hydrogels were analyzed for expression of regular stem cell markers and their tumor genericity. Microarray analysis was performed to identify meningioma stem cell specific markers and to examine the application of such marker molecules as a therapeutic targets or pathological diagnosis for grading. Results: Regular stem cell markers such as Nanog , and Oct3/4 were induced by culturing meningioma cells on hydrogels, and comprehensive gene expression analysis identified molecules involved in cancer stem cell activity. Among them, CXCR4 was selected as a therapeutic target molecule. Stimulation of CXCR4 via CXCL12 led to an increase in stem cell markers. In human meningioma pathological specimens and cultured cell lines, there was a correlation between CXCR4 expression levels and NF2 mutations and/or deletions. CXCR4 immunohistochemistry also detected along with the brain invasion. Thus, CXCR4 immunohistochemistry may be useful to suggest typical CNS WHO grade 1 meningioma, that do not require molecular analysis. Conclusions: We have defined meningioma stem cell signature via HARP phenomenon and identified CXCR4 with biological significance as being diagnostic target. Key Points: We induce meningioma stem signature via Hydrogel activated reprogramming (HARP) phenomena. We identified CXCR4 as a candidate molecule as stemness marker and therapeutic target. Translational research using pathological specimens reveal CXCR4 immunohistochemistry has been shown to play an auxiliary role in the diagnosis of meningiomas. Importance of the Study: In addition to morphology, immunohistochemistry and gene alteration are being adopted as diagnostic criteria for CNS tumors. From CNS5 onwards, epigenetic changes such as methylation analysis are being adopted as diagnostic criteria. We induced epigenetic changes in meningioma cells and induced cancer stemness, and this technique will be of great importance in the research and diagnosis of meningioma. In addition, microarray analysis was used to select CXCR4 from the molecules that increased simultaneously during stem cell induction on the three hydrogels, and further analysis revealed that CXCR4 immunostaining may indicate the distribution of meningioma stem cells, also making it useful for diagnosis. This report will contribute to the advancement of meningioma research and diagnosis by conducting basic research and using histopathological specimens.
Open AccessInduction of meningioma stem signature via hydrogel reprogramming and application of meningioma stem cell marker CXCR4 to pathological diagnosis and treatment
Backgrounds: Meningioma accounts for about 40% of brain tumors, but there was no effective treatment for recurrent or inoperable cases. We have previously found that when cancer cells are cultured on certain hydrogels, cancer stem cells are efficiently induced in various cancer types and we named this process as hydrogel activated reprogramming (HARP) phenomenon. In this study, we aimed to identify a key molecule that induced meningioma stem cells via hydrogels. Methods: Meningioma cells cultured on hydrogels were analyzed for expression of regular stem cell markers and their tumor genericity. Microarray analysis was performed to identify meningioma stem cell specific markers and to examine the application of such marker molecules as a therapeutic targets or pathological diagnosis for grading. Results: Regular stem cell markers such as Nanog , and Oct3/4 were induced by culturing meningioma cells on hydrogels, and comprehensive gene expression analysis identified molecules involved in cancer stem cell activity. Among them, CXCR4 was selected as a therapeutic target molecule. Stimulation of CXCR4 via CXCL12 led to an increase in stem cell markers. In human meningioma pathological specimens and cultured cell lines, there was a correlation between CXCR4 expression levels and NF2 mutations and/or deletions. CXCR4 immunohistochemistry also detected along with the brain invasion. Thus, CXCR4 immunohistochemistry may be useful to suggest typical CNS WHO grade 1 meningioma, that do not require molecular analysis. Conclusions: We have defined meningioma stem cell signature via HARP phenomenon and identified CXCR4 with biological significance as being diagnostic target. Key Points: We induce meningioma stem signature via Hydrogel activated reprogramming (HARP) phenomena. We identified CXCR4 as a candidate molecule as stemness marker and therapeutic target. Translational research using pathological specimens reveal CXCR4 immunohistochemistry has been shown to play an auxiliary role in the diagnosis of meningiomas. Importance of the Study: In addition to morphology, immunohistochemistry and gene alteration are being adopted as diagnostic criteria for CNS tumors. From CNS5 onwards, epigenetic changes such as methylation analysis are being adopted as diagnostic criteria. We induced epigenetic changes in meningioma cells and induced cancer stemness, and this technique will be of great importance in the research and diagnosis of meningioma. In addition, microarray analysis was used to select CXCR4 from the molecules that increased simultaneously during stem cell induction on the three hydrogels, and further analysis revealed that CXCR4 immunostaining may indicate the distribution of meningioma stem cells, also making it useful for diagnosis. This report will contribute to the advancement of meningioma research and diagnosis by conducting basic research and using histopathological specimens.
- Open Access
- 27 November 2024
- Published by Springer Nature in Research Square
Data-Driven De Novo Design of Super-Adhesive Hydrogels
Data-driven methodologies have revolutionized the discovery and prediction of new hard materials, such as crystal structures and high-entropy alloys1-5. However, their application to soft materials remains challenging due to the inherent complexity of their structure–property relationships6-8. Here, we present a comprehensive data-driven approach that integrates data mining, experimentation, and machine learning to develop high-performance adhesive hydrogels from scratch, tailored for demanding underwater environments. By leveraging protein databases, we devised a descriptor strategy to statistically replicate protein sequence patterns via ideal random copolymerization, enabling targeted hydrogel design and dataset construction. Using machine learning, we optimized hydrogel formulations even with a small dataset, achieving unprecedented adhesive performance. These super-adhesive hydrogels demonstrate immense potential across diverse applications, from biomedical engineering to deep-sea exploration, marking a significant advancement in the data-driven innovation for soft materials.
- 27 November 2024
- Published by Springer Nature in Research Square
Open AccessData-Driven De Novo Design of Super-Adhesive Hydrogels
Data-driven methodologies have revolutionized the discovery and prediction of new hard materials, such as crystal structures and high-entropy alloys1-5. However, their application to soft materials remains challenging due to the inherent complexity of their structure–property relationships6-8. Here, we present a comprehensive data-driven approach that integrates data mining, experimentation, and machine learning to develop high-performance adhesive hydrogels from scratch, tailored for demanding underwater environments. By leveraging protein databases, we devised a descriptor strategy to statistically replicate protein sequence patterns via ideal random copolymerization, enabling targeted hydrogel design and dataset construction. Using machine learning, we optimized hydrogel formulations even with a small dataset, achieving unprecedented adhesive performance. These super-adhesive hydrogels demonstrate immense potential across diverse applications, from biomedical engineering to deep-sea exploration, marking a significant advancement in the data-driven innovation for soft materials.
- Top Cited PapersOpen Access
- 8 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
Circulation of SARS-CoV-2 Omicron XBB has resulted in the emergence of XBB.1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB.1.5 evolved from XBB.1 by acquiring the S486P spike (S) mutation, subsequent to the acquisition of a nonsense mutation in ORF8. Neutralization assays showed similar abilities of immune escape between XBB.1.5 and XBB.1. We determine the structural basis for the interaction between human ACE2 and the S protein of XBB.1.5, showing similar overall structures between the S proteins of XBB.1 and XBB.1.5. We provide the intrinsic pathogenicity of XBB.1 and XBB.1.5 in hamsters. Importantly, we find that the ORF8 nonsense mutation of XBB.1.5 resulted in impairment of MHC suppression. In vivo experiments using recombinant viruses reveal that the XBB.1.5 mutations are involved with reduced virulence of XBB.1.5. Together, our study identifies the two viral functions defined the difference between XBB.1 and XBB.1.5.
- 8 February 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Top Cited PapersOpen AccessVirological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
Circulation of SARS-CoV-2 Omicron XBB has resulted in the emergence of XBB.1.5, a new Variant of Interest. Our phylogenetic analysis suggests that XBB.1.5 evolved from XBB.1 by acquiring the S486P spike (S) mutation, subsequent to the acquisition of a nonsense mutation in ORF8. Neutralization assays showed similar abilities of immune escape between XBB.1.5 and XBB.1. We determine the structural basis for the interaction between human ACE2 and the S protein of XBB.1.5, showing similar overall structures between the S proteins of XBB.1 and XBB.1.5. We provide the intrinsic pathogenicity of XBB.1 and XBB.1.5 in hamsters. Importantly, we find that the ORF8 nonsense mutation of XBB.1.5 resulted in impairment of MHC suppression. In vivo experiments using recombinant viruses reveal that the XBB.1.5 mutations are involved with reduced virulence of XBB.1.5. Together, our study identifies the two viral functions defined the difference between XBB.1 and XBB.1.5.
- Open Access
- 24 July 2023
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-12
Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
The unremitting emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants necessitates ongoing control measures. Given its rapid spread, the new Omicron subvariant BA.5 requires urgent characterization. Here, we comprehensively analyzed BA.5 with the other Omicron variants BA.1, BA.2, and ancestral B.1.1. Although in vitro growth kinetics of BA.5 was comparable among the Omicron subvariants, BA.5 was much more fusogenic than BA.1 and BA.2. Airway-on-a-chip analysis showed that, among Omicron subvariants, BA.5 had enhanced ability to disrupt the respiratory epithelial and endothelial barriers. Furthermore, in our hamster model, in vivo pathogenicity of BA.5 was slightly higher than that of the other Omicron variants and less than that of ancestral B.1.1. Notably, BA.5 gains efficient virus spread compared with BA.1 and BA.2, leading to prompt immune responses. Our findings suggest that BA.5 has low pathogenicity compared with the ancestral strain but enhanced virus spread /inflammation compared with earlier Omicron subvariants.
- 24 July 2023
- Published by Springer Nature in Communications Biology
- Vol. 6 (1) , 1-12
Open AccessComparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
The unremitting emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants necessitates ongoing control measures. Given its rapid spread, the new Omicron subvariant BA.5 requires urgent characterization. Here, we comprehensively analyzed BA.5 with the other Omicron variants BA.1, BA.2, and ancestral B.1.1. Although in vitro growth kinetics of BA.5 was comparable among the Omicron subvariants, BA.5 was much more fusogenic than BA.1 and BA.2. Airway-on-a-chip analysis showed that, among Omicron subvariants, BA.5 had enhanced ability to disrupt the respiratory epithelial and endothelial barriers. Furthermore, in our hamster model, in vivo pathogenicity of BA.5 was slightly higher than that of the other Omicron variants and less than that of ancestral B.1.1. Notably, BA.5 gains efficient virus spread compared with BA.1 and BA.2, leading to prompt immune responses. Our findings suggest that BA.5 has low pathogenicity compared with the ancestral strain but enhanced virus spread /inflammation compared with earlier Omicron subvariants.